Outlook Therapeutics Inc

Company Snapshot
111 S. Wood Avenue
Iselin, NJ 08852
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 23
Please select from the dropdown
Company Financials

2022
2023
2024
Gross Profit
Operating Income
-$63,070,753
-$53,126,382
-$71,703,235
Net Income
-$66,052,264
-$58,982,668
-$75,366,714
2022
Gross Profit
Operating Income
-$63,070,753
Net Income
-$66,052,264
2023
Gross Profit
Operating Income
-$53,126,382
Net Income
-$58,982,668
2024
Gross Profit
Operating Income
-$71,703,235
Net Income
-$75,366,714
The above data on Outlook Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Chief Commercial Officer
$450,000
$316,859
$1,170
$768,029
$768,029
Chief Commercial Officer
Chief Financial Officer, Interim Chief Executive Officer, Executive Vice President Treasurer, Secretary, Principal Accounting Officer and Director
$475,000
$158,427
$1,170
$634,597
$634,597
Chief Financial Officer, Interim Chief Executive Officer, Executive Vice President Treasurer, Secretary, Principal Accounting Officer and Director
Executive Chairman of the Board
$207,500
$35,000
$0
$242,500
$242,500
Executive Chairman of the Board
Independent Director
$78,000
$35,000
$0
$113,000
$113,000
Independent Director
Independent Director
$77,500
$35,000
$0
$112,500
$112,500
Independent Director
Outlook Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2024. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us